Table 3.
Open in new tab

Medication persistence among PWs and HWs 12 months after treatment initiation.

PWHW
Persistence, n (%)TCZTNFiABTTCZTNFiABT
6 months32
(97.0)		100
(90.1)		24
(96.0)		25
(92.6)		44
(86.3)		27
(96.4)
12 months29
(93.5)		92
(82.9)		23
(85.2)		25
(89.3)		37
(84.1)		20
(87.0)
PWHW
Persistence, n (%)TCZTNFiABTTCZTNFiABT
6 months32
(97.0)		100
(90.1)		24
(96.0)		25
(92.6)		44
(86.3)		27
(96.4)
12 months29
(93.5)		92
(82.9)		23
(85.2)		25
(89.3)		37
(84.1)		20
(87.0)

n: number of patients.

Table 3.
Open in new tab

Medication persistence among PWs and HWs 12 months after treatment initiation.

PWHW
Persistence, n (%)TCZTNFiABTTCZTNFiABT
6 months32
(97.0)		100
(90.1)		24
(96.0)		25
(92.6)		44
(86.3)		27
(96.4)
12 months29
(93.5)		92
(82.9)		23
(85.2)		25
(89.3)		37
(84.1)		20
(87.0)
PWHW
Persistence, n (%)TCZTNFiABTTCZTNFiABT
6 months32
(97.0)		100
(90.1)		24
(96.0)		25
(92.6)		44
(86.3)		27
(96.4)
12 months29
(93.5)		92
(82.9)		23
(85.2)		25
(89.3)		37
(84.1)		20
(87.0)

n: number of patients.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close